MetaCap

Celldex Therapeutics (CLDX) News

NASDAQ: CLDXHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD

27.42-0.54 (-1.93%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

CLDX news summary

We found 5 recent headlines mentioning Celldex Therapeutics (CLDX): 2 in the past week and 3 in the past 30 days, most often from Nasdaq, GlobeNewswire, PR Newswire. For price context, CLDX is down 1.93% at $27.42. The most recent story, "Celldex Ends Barzolvolimab Development In Atopic Dermatitis After Phase 2 Trial Misses Key Endpoints", was published by Nasdaq on Nov 20, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Celldex Therapeutics headlines

Stocks mentioned alongside CLDX

Compare CLDX